跳至主要内容
临床试验/NCT03843281
NCT03843281已完成4 期

Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Bruno Minotti1 个研究点 分布在 1 个国家目标入组 222 人开始时间: 2019年5月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
222
试验地点
1
主要终点
Assessment of the total dose of morphine till pain < 4 on the NRS (0-10) after the first infusion of paracetamol or placebo.

研究概览

简要总结

The purpose of this study is to test the additional effect of paracetamol in combination with morphine for analgesia, respectively to test/confirm an opioid sparing effect due to the additional use of Paracetamol, as well as the reduction of adverse drug reactions of morphine.

详细描述

Paracetamol (acetaminophen) is widely used around the world for mild to moderate pain in all age groups. Prescription at the emergency department is very common and some studies suggest the use in alternative of Morphine, at least in the renal colic.

Morphine has also a complex analgesic effect due to inhibition of µ Receptors in the central nervous system and in the dorsal horn of the spinal cord. Morphine (like other opioids) is accepted as a cornerstone of acute pain management in the emergency department. However, occurrence of adverse drug reactions is up to 25%, mainly nausea and drowsiness.

The use of paracetamol in addition to morphine showed in a meta-analysis in the post-operative setting an opioid sparing effect of 20% over the first postoperative 24 hours, but did not change the incidence of morphine-related adverse effects in the postoperative period. An additive effect was showed of the two medicaments in another Study measuring the median effective analgesic dose (ED50).

The purpose of this study is to test the additional effect of paracetamol in combination with morphine for analgesia, respectively to test/confirm an opioid sparing effect due to the additional use of Paracetamol, as well as the to reduction of adverse drug reactions of morphine.

The study is a multicenter, randomized, double-blind, placebo-controlled. We randomize patients with pain-score >=4 on a pain Scala of 0-10 Points (numeric rating scale) in two group, one with paracetamol, one with placebo to investigate the (additive) effect of paracetamol in combination with morphine. The treatment team and the patients will be blinded to the administration. The study design is outlined to confirm the result of previous studies who stated a 20% reduction of morphine doses when combined with paracetamol. Study duration for each patient would be 240 min.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with pain with Pain-score is more or equal than four in a numeric rating scale from zero to ten (i.e. indication for a treatment with morphine)
  • Age over 18
  • Signed informed consent. In case, patient is not able to sign the informed consent due to pain, at least verbal consent has to be provided. After pain relief, written informed consent with data and time has to be obtained

排除标准

  • Analgesia in the past last 6 hours prior to visit at the emergency department
  • Current Analgesia with long-acting/extended-release drugs
  • Current Analgesia with opioids
  • Chronic pain syndrome
  • Contraindication for either paracetamol or morphine
  • Patient's refusal of paracetamol or morphine treatment
  • Pregnancy or Breastfeeding
  • GCS < 13
  • SpO2 < 90% with a maximum of 4 L/Min O2
  • Systolic Blood Pressure < 90 mmHg
  • "Fast Track"/Notfallpraxis patients

研究组 & 干预措施

Paracetamol

Experimental

Paracetamol 1 g (100 mL) IV + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours

干预措施: Paracetamol (Drug)

Paracetamol

Experimental

Paracetamol 1 g (100 mL) IV + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours

干预措施: Morphine (Drug)

Placebo

Placebo Comparator

Placebo (NaCl 0.9% 100 mL IV) + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

Placebo (NaCl 0.9% 100 mL IV) + Morphine 0.1 mg/kg IV (repeatable in Doses of 0.05 mg/kg), 100 patients over 4 hours

干预措施: Morphine (Drug)

结局指标

主要结局

Assessment of the total dose of morphine till pain < 4 on the NRS (0-10) after the first infusion of paracetamol or placebo.

时间窗: up to 4 hours

次要结局

  • Assessment of time interval of pain < 4 on the NRS (after been achieved)(up to 4 hours)
  • Total dose of morphine within the first 4 hours after the first infusion of paracetamol or Placebo.(up to 4 hours)
  • Prevalence of morphine adverse reactions within the first 4 hours after infusion of paracetamol or placebo(up to 4 hours, respectively in case of serious adverse events up to recovery time of the patient)

研究者

发起方
Bruno Minotti
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Bruno Minotti

Sponsor-Investigator

Cantonal Hospital of St. Gallen

研究点 (1)

Loading locations...

相似试验